Net profit of Hester Biosciences declined 64.43% to Rs 3.98 crore in the quarter ended December 2023 as against Rs 11.19 crore during the previous quarter ended December 2022. Sales declined 10.62% to Rs 66.98 crore in the quarter ended December 2023 as against Rs 74.94 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales66.9874.94 -11 OPM %15.1525.03 - PBDT10.1621.24 -52 PBT6.4116.00 -60 NP3.9811.19 -64 Powered by Capital Market - Live News

Hester Biosciences will hold a meeting of the Board of Directors of the Company on 2 February 2024.Powered by Capital Market - Live News

Net profit of Hester Biosciences declined 41.07% to Rs 4.09 crore in the quarter ended September 2023 as against Rs 6.94 crore during the previous quarter ended September 2022. Sales declined 3.68% to Rs 70.46 crore in the quarter ended September 2023 as against Rs 73.15 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales70.4673.15 -4 OPM %18.7517.43 - PBDT11.0515.30 -28 PBT6.7610.27 -34 NP4.096.94 -41 Powered by Capital Market - Live News

Hester Biosciences will hold a meeting of the Board of Directors of the Company on 7 November 2023.Powered by Capital Market - Live News

Hester Biosciences announced that the 36th Annual General Meeting (AGM) of the company will be held on 20 September 2023.Powered by Capital Market - Live News